Orphan Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014555480
Market Monitor Global
Oct-2021
Life Sciences
106 Pages

This report contains market size and forecasts of Orphan Drugs in global, including the following market information:
Global Orphan Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Orphan Drugs Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Orphan Drugs companies in 2020 (%)
The global Orphan Drugs market was valued at 126280 million in 2020 and is projected to reach US$ 180110 million by 2027, at a CAGR of 9.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orphan Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, By Type, 2020 (%)
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic Disorders
Endocrinology
Infectious Diseases
Others

Global Orphan Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail pharmacies
Others

Global Orphan Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Orphan Drugs revenues share in global market, 2020 (%)
Key companies Orphan Drugs sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Orphan Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bristol-Myers Squibb Company
Celgene
F. Hoffmann-La Roche
Pfizer
Sanofi
Alexion Pharmaceuticals
Eli Lilly and Company
Novo Nordisk
AstraZeneca
Eisai
Daiichi Sankyo Company
Bayer
GlaxoSmithKline
Merck & Co
Johnson & Johnson
Biogen
Takeda
Amgen

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Orphan Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orphan Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs Overall Market Size
2.1 Global Orphan Drugs Market Size: 2021 VS 2027
2.2 Global Orphan Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Orphan Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Orphan Drugs Players in Global Market
3.2 Top Global Orphan Drugs Companies Ranked by Revenue
3.3 Global Orphan Drugs Revenue by Companies
3.4 Global Orphan Drugs Sales by Companies
3.5 Global Orphan Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Orphan Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Orphan Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Orphan Drugs Players in Global Market
3.8.1 List of Global Tier 1 Orphan Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Orphan Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Orphan Drugs Market Size Markets, 2021 & 2027
4.1.2 Oncology
4.1.3 Gastrointestinal
4.1.4 Pulmonary
4.1.5 Neurology
4.1.6 Hematology
4.1.7 Cardio-vascular
4.1.8 Metabolic Disorders
4.1.9 Endocrinology
4.1.10 Infectious Diseases
4.1.11 Others
4.2 By Type - Global Orphan Drugs Revenue & Forecasts
4.2.1 By Type - Global Orphan Drugs Revenue, 2016-2021
4.2.2 By Type - Global Orphan Drugs Revenue, 2022-2027
4.2.3 By Type - Global Orphan Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Orphan Drugs Sales & Forecasts
4.3.1 By Type - Global Orphan Drugs Sales, 2016-2021
4.3.2 By Type - Global Orphan Drugs Sales, 2022-2027
4.3.3 By Type - Global Orphan Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Orphan Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orphan Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail pharmacies
5.1.4 Others
5.2 By Application - Global Orphan Drugs Revenue & Forecasts
5.2.1 By Application - Global Orphan Drugs Revenue, 2016-2021
5.2.2 By Application - Global Orphan Drugs Revenue, 2022-2027
5.2.3 By Application - Global Orphan Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Orphan Drugs Sales & Forecasts
5.3.1 By Application - Global Orphan Drugs Sales, 2016-2021
5.3.2 By Application - Global Orphan Drugs Sales, 2022-2027
5.3.3 By Application - Global Orphan Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Orphan Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Orphan Drugs Market Size, 2021 & 2027
6.2 By Region - Global Orphan Drugs Revenue & Forecasts
6.2.1 By Region - Global Orphan Drugs Revenue, 2016-2021
6.2.2 By Region - Global Orphan Drugs Revenue, 2022-2027
6.2.3 By Region - Global Orphan Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Orphan Drugs Sales & Forecasts
6.3.1 By Region - Global Orphan Drugs Sales, 2016-2021
6.3.2 By Region - Global Orphan Drugs Sales, 2022-2027
6.3.3 By Region - Global Orphan Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Orphan Drugs Revenue, 2016-2027
6.4.2 By Country - North America Orphan Drugs Sales, 2016-2027
6.4.3 US Orphan Drugs Market Size, 2016-2027
6.4.4 Canada Orphan Drugs Market Size, 2016-2027
6.4.5 Mexico Orphan Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Orphan Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Orphan Drugs Sales, 2016-2027
6.5.3 Germany Orphan Drugs Market Size, 2016-2027
6.5.4 France Orphan Drugs Market Size, 2016-2027
6.5.5 U.K. Orphan Drugs Market Size, 2016-2027
6.5.6 Italy Orphan Drugs Market Size, 2016-2027
6.5.7 Russia Orphan Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Orphan Drugs Market Size, 2016-2027
6.5.9 Benelux Orphan Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Orphan Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Orphan Drugs Sales, 2016-2027
6.6.3 China Orphan Drugs Market Size, 2016-2027
6.6.4 Japan Orphan Drugs Market Size, 2016-2027
6.6.5 South Korea Orphan Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Orphan Drugs Market Size, 2016-2027
6.6.7 India Orphan Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Orphan Drugs Revenue, 2016-2027
6.7.2 By Country - South America Orphan Drugs Sales, 2016-2027
6.7.3 Brazil Orphan Drugs Market Size, 2016-2027
6.7.4 Argentina Orphan Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Orphan Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Orphan Drugs Sales, 2016-2027
6.8.3 Turkey Orphan Drugs Market Size, 2016-2027
6.8.4 Israel Orphan Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Orphan Drugs Market Size, 2016-2027
6.8.6 UAE Orphan Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Orphan Drugs Major Product Offerings
7.1.4 Novartis Orphan Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Novartis Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Orphan Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Orphan Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Celgene
7.3.1 Celgene Corporate Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Orphan Drugs Major Product Offerings
7.3.4 Celgene Orphan Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Celgene Key News
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Corporate Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Orphan Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Orphan Drugs Sales and Revenue in Global (2016-2021)
7.4.5 F. Hoffmann-La Roche Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Orphan Drugs Major Product Offerings
7.5.4 Pfizer Orphan Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Pfizer Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Orphan Drugs Major Product Offerings
7.6.4 Sanofi Orphan Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Sanofi Key News
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Corporate Summary
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Orphan Drugs Major Product Offerings
7.4.4 Alexion Pharmaceuticals Orphan Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Alexion Pharmaceuticals Key News
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Orphan Drugs Major Product Offerings
7.8.4 Eli Lilly and Company Orphan Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Eli Lilly and Company Key News
7.9 Novo Nordisk
7.9.1 Novo Nordisk Corporate Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Orphan Drugs Major Product Offerings
7.9.4 Novo Nordisk Orphan Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Novo Nordisk Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Orphan Drugs Major Product Offerings
7.10.4 AstraZeneca Orphan Drugs Sales and Revenue in Global (2016-2021)
7.10.5 AstraZeneca Key News
7.11 Eisai
7.11.1 Eisai Corporate Summary
7.11.2 Eisai Orphan Drugs Business Overview
7.11.3 Eisai Orphan Drugs Major Product Offerings
7.11.4 Eisai Orphan Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Eisai Key News
7.12 Daiichi Sankyo Company
7.12.1 Daiichi Sankyo Company Corporate Summary
7.12.2 Daiichi Sankyo Company Orphan Drugs Business Overview
7.12.3 Daiichi Sankyo Company Orphan Drugs Major Product Offerings
7.12.4 Daiichi Sankyo Company Orphan Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Daiichi Sankyo Company Key News
7.13 Bayer
7.13.1 Bayer Corporate Summary
7.13.2 Bayer Orphan Drugs Business Overview
7.13.3 Bayer Orphan Drugs Major Product Offerings
7.13.4 Bayer Orphan Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Bayer Key News
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporate Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Orphan Drugs Major Product Offerings
7.14.4 GlaxoSmithKline Orphan Drugs Sales and Revenue in Global (2016-2021)
7.14.5 GlaxoSmithKline Key News
7.15 Merck & Co
7.15.1 Merck & Co Corporate Summary
7.15.2 Merck & Co Business Overview
7.15.3 Merck & Co Orphan Drugs Major Product Offerings
7.15.4 Merck & Co Orphan Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Merck & Co Key News
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporate Summary
7.16.2 Johnson & Johnson Business Overview
7.16.3 Johnson & Johnson Orphan Drugs Major Product Offerings
7.16.4 Johnson & Johnson Orphan Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Johnson & Johnson Key News
7.17 Biogen
7.17.1 Biogen Corporate Summary
7.17.2 Biogen Business Overview
7.17.3 Biogen Orphan Drugs Major Product Offerings
7.17.4 Biogen Orphan Drugs Sales and Revenue in Global (2016-2021)
7.17.5 Biogen Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Orphan Drugs Major Product Offerings
7.18.4 Takeda Orphan Drugs Sales and Revenue in Global (2016-2021)
7.18.5 Takeda Key News
7.19 Amgen
7.19.1 Amgen Corporate Summary
7.19.2 Amgen Business Overview
7.19.3 Amgen Orphan Drugs Major Product Offerings
7.19.4 Amgen Orphan Drugs Sales and Revenue in Global (2016-2021)
7.19.5 Amgen Key News
8 Global Orphan Drugs Production Capacity, Analysis
8.1 Global Orphan Drugs Production Capacity, 2016-2027
8.2 Orphan Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Orphan Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Orphan Drugs Supply Chain Analysis
10.1 Orphan Drugs Industry Value Chain
10.2 Orphan Drugs Upstream Market
10.3 Orphan Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Orphan Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Orphan Drugs in Global Market
Table 2. Top Orphan Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Orphan Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Orphan Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Orphan Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Orphan Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Orphan Drugs Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Orphan Drugs Product Type
Table 9. List of Global Tier 1 Orphan Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orphan Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE